Skip to Main Content

Author Details

Guilherme Suarez-Kurtz
Instituto Nacional de Cancer
1968
205
36
Vardit Ravitsky (CM4AI)
PMIDPaper TitleJournal TitlePublished Year
36893562CYP2C19 metabolic estrogen phenotypes and endometriosis risk in Brazilian women.Clinics (Sao Paulo)2023
37767624The c.415C>T polymorphism in NUDT15 is more frequent than the polymorphisms in TPMT in Chilean patients who use thiopurine drugs.Pharmacogenet Genomics2023
37161547Implementation of DPYD Genotyping in Admixed American Populations: Brazil as a Model Case.Clin Pharmacol Ther2023
37025454Distribution of a novel <i>CYP2C</i> haplotype in Native American populations.Front Genet2023
37156205Pharmacogenetic testing for thiopurine drugs in Brazilian acute lymphoblastic leukemia patients.Clinics (Sao Paulo)2023
37234706Characterization of pharmacogenomic variants in a Brazilian admixed cohort of elderly individuals based on whole-genome sequencing data.Front Pharmacol2023
35042408Pharmacogenetic differentiation across Latin America.Pharmacogenomics2022
35837282Functional Restoration of <i>BRCA1</i> Nonsense Mutations by Aminoglycoside-Induced Readthrough.Front Pharmacol2022
35496269Single Nucleotide Variants as Proxies for <i>HLA-A*31:01</i> in Native American Populations.Front Pharmacol2022
35514050Pharmacogenetic predictors of variability in efavirenz pharmacokinetics in an admixed Brazilian HIV cohort.Br J Clin Pharmacol2022
36171434Assessment of small in-frame indels and C-terminal nonsense variants of BRCA1 using a validated functional assay.Sci Rep2022
32997351Impact of Plasmodium vivax malaria and antimalarial treatment on cytochrome P450 activity in Brazilian patients.Br J Clin Pharmacol2021
34042179Impact of CYP2D6 Genetic Variation on Radical Cure of Plasmodium vivax Malaria.Clin Pharmacol Ther2021
33110249Population impact of pharmacogenetic tests in admixed populations across the Americas.Pharmacogenomics J2021
33441860Identification of ancestry proportions in admixed groups across the Americas using clinical pharmacogenomic SNP panels.Sci Rep2021
32453263Pharmacogenomics of thiopurines: distribution of TPMT and NUDT15 polymorphisms in the Brazilian Amazon.Pharmacogenet Genomics2020
31758654Post-marketing assessment of generic tamoxifen in Brazilian breast cancer patients.Basic Clin Pharmacol Toxicol2020
31936331Network of Interactions between ZIKA Virus Non-Structural Proteins and Human Host Proteins.Cells2020
31869433Genetic Factors Influencing Warfarin Dose in Black-African Patients: A Systematic Review and Meta-Analysis.Clin Pharmacol Ther2020
31651720Pharmacogeomic implications of population diversity in Latin America: TPMT and NUDT15 polymorphisms and thiopurine dosing.Pharmacogenet Genomics2020
32187157Distribution and linkage disequilibrium of the enhancer SNP rs5758550 among Latin American populations: influence of continental ancestry.Pharmacogenet Genomics2020
32247187A background subtraction approach for determination of endogenous cortisol and 6β-hydroxycortisol in urine by UPLC-MS/MS with application in a within-day variability study in HIV-infected pregnant women.J Chromatogr B Analyt Technol Biomed Life Sci2020
32174823Limited Sampling Modeling for Estimation of Phenotypic Metrics for CYP Enzymes and the ABCB1 Transporter Using a Cocktail Approach.Front Pharmacol2020
32378980Implementation of a pharmacogenomic program in a Brazilian public institution.Pharmacogenomics2020
30506689Effect of CYP4F2, VKORC1, and CYP2C9 in Influencing Coumarin Dose: A Single-Patient Data Meta-Analysis in More Than 15,000 Individuals.Clin Pharmacol Ther2019
31852530Hormonal status affects plasma exposure of tamoxifen and its main metabolites in tamoxifen-treated breast cancer patients.BMC Pharmacol Toxicol2019
315888764th ESPT Conference: pharmacogenomics and personalized medicine - research progress and clinical implementation.Pharmacogenomics2019
30897207NUDT15 Polymorphism in Native American Populations of Brazil.Clin Pharmacol Ther2019
30765603Impact of amino acid substitutions at secondary structures in the BRCT domains of the tumor suppressor BRCA1: Implications for clinical annotation.J Biol Chem2019
30515762Pharmacogene Variation Consortium Gene Introduction: NUDT15.Clin Pharmacol Ther2019
30537134Conference report: pharmacogenomics in special populations at WCP2018.Br J Clin Pharmacol2019
30447069Clinical Pharmacogenetics Implementation Consortium Guideline for Thiopurine Dosing Based on TPMT and NUDT15 Genotypes: 2018 Update.Clin Pharmacol Ther2019
30589990Pharmacogenomics research and clinical implementation in Brazil.Basic Clin Pharmacol Toxicol2019
29352482Influence of pharmacogenetic polymorphisms and demographic variables on metformin pharmacokinetics in an admixed Brazilian cohort.Br J Clin Pharmacol2018
29801573Population Diversity in Pharmacogenetics: A Latin American Perspective.Adv Pharmacol2018
30328952Pharmacogenetic testing in oncology: a Brazilian perspective.Clinics (Sao Paulo)2018
30301969Uncovering association networks through an eQTL analysis involving human miRNAs and lincRNAs.Sci Rep2018
29390987CYP2D6 activity and the risk of recurrence of Plasmodium vivax malaria in the Brazilian Amazon: a prospective cohort study.Malar J2018
28858227The Role of PALB2 in the DNA Damage Response and Cancer Predisposition.Int J Mol Sci2017
28278048BRCA1 recruitment to damaged DNA sites is dependent on CDK9.Cell Cycle2017
28475402DNA repair genes PAXIP1 and TP53BP1 expression is associated with breast cancer prognosis.Cancer Biol Ther2017
28263279Differential effects of predictors of warfarin dose according to race/color categories in the admixed Brazilian population.Pharmacogenet Genomics2017
27136043Single nucleotide polymorphism coverage and inference of N-acetyltransferase-2 acetylator phenotypes in wordwide population groups.Pharmacogenet Genomics2016
27631188Conference Report: First Pharmacogenetics and Precision Medicine Conference in Africa (April 7-9, 2016, Cape Town, South Africa).OMICS2016
27206639A phase I study of mTOR inhibitor everolimus in association with cisplatin and radiotherapy for the treatment of locally advanced cervix cancer: PHOENIX I.Cancer Chemother Pharmacol2016
27527610L-thyroxine doses required for TSH suppression in patients with differentiated thyroid cancer: Effect of a novel UGT1 marker, rs11563250A &gt; G.Br J Clin Pharmacol2016
27324407Limited sampling strategy for determining metformin area under the plasma concentration-time curve.Br J Clin Pharmacol2016
25345887Pharmacogenetics of coumarin anticoagulants in Brazilians.Expert Opin Drug Metab Toxicol2015
26265036Genome-wide association study of warfarin maintenance dose in a Brazilian sample.Pharmacogenomics2015
25940755Impact of visceral leishmaniasis and curative chemotherapy on cytochrome P450 activity in Brazilian patients.Br J Clin Pharmacol2015
  • 1 - 50 of 205

Recommended Authors

University of Pennsylvania.
Career Start Year 1995
Number of shared co-authors 1
The University of Danang-University of Science and Technology
Career Start Year 1993
Number of shared co-authors 3
University of Virginia School of Medicine
Career Start Year 1993
Number of shared co-authors 0
University of California San Francisco
Career Start Year 1993
Number of shared co-authors 9
Marshall University, Joan C. Edwards School of Medicine
Career Start Year 1992
Number of shared co-authors 0
BC Children's Hospital Research Institute
Career Start Year 1991
Number of shared co-authors 7
University of Louisville
Career Start Year 1991
Number of shared co-authors 1
University of South Dakota Sanford School of Medicine
Career Start Year 1989
Number of shared co-authors 14
Mayo Clinic
Career Start Year 1985
Number of shared co-authors 7
Westmead Hospital
Career Start Year 1983
Number of shared co-authors 1
Massachusetts General Hospital
Career Start Year 1982
Number of shared co-authors 0
University of Western Australia
Career Start Year 1980
Number of shared co-authors 6
Vanderbilt University Medical Center
Career Start Year 1980
Number of shared co-authors 31
Department of Pharmaceutics, University of Florida
Career Start Year 1979
Number of shared co-authors 11
Center for Drug Evaluation and Research
Career Start Year 1978
Number of shared co-authors 1
University of California San Francisco
Career Start Year 1978
Number of shared co-authors 15
University of Helsinki and Helsinki University Hospital
Career Start Year 1977
Number of shared co-authors 0
Mass General Hospital
Career Start Year 1977
Number of shared co-authors 0
Georgetown and Howard Universities Center for Clinical and Translational Science
Career Start Year 1976
Number of shared co-authors 1
Harvard T.H. Chan School of Public Health
Career Start Year 1975
Number of shared co-authors 0
Inc., Canada Cardiovascular Research Institute, Stanford University
Career Start Year 1975
Number of shared co-authors 0
Vanderbilt University
Career Start Year 1974
Number of shared co-authors 1
Health Outcomes Associates Limited and University of Auckland
Career Start Year 1972
Number of shared co-authors 0
Center for Andrology and Sexual Medicine, Viet Duc University Hospital
Career Start Year 1970
Number of shared co-authors 0
Perelman School of Medicine, University of Pennsylvania
Career Start Year 1968
Number of shared co-authors 1
Mayo Clinic
Career Start Year 1968
Number of shared co-authors 16
College of Medicine, The Ohio State University
Career Start Year 1967
Number of shared co-authors 13
ICAR-Central Institute of Fisheries Education
Career Start Year 1964
Number of shared co-authors 0
School of Public Health, University of Alabama at Birmingham
Career Start Year 1963
Number of shared co-authors 7

Collaborators

Co-authored papers 12
Instituto Nacional de Cancer, Programa de Pesquisa Clinica
Co-authored papers 10
H. Lee Moffitt Cancer Center & Research Institute
Co-authored papers 9
Co-authored papers 8
Department of Pharmacotherapy and Translational Research, University of Florida
Co-authored papers 5
Stanford University
Co-authored papers 4
Stanford University
Co-authored papers 4
Heersink School of Medicine, University of Alabama at Birmingham
Co-authored papers 4
Department of Pharmacotherapy and Translational Research, University of Florida
Co-authored papers 4
A.C. Camargo Cancer Center
Co-authored papers 3
Cardiovascular Research Center, Massachusetts General Hospital
Co-authored papers 3
Instituto do Cancer do Estado de Sao Paulo, Faculdade de Medicina de Sao Paulo
Co-authored papers 2
Stanford University
Co-authored papers 2
Stanford University
Co-authored papers 2
Co-authored papers 2
Mayo Clinic
Co-authored papers 2
and of Biochemistry and Pharmacy, University of Tuebingen
Co-authored papers 2
University of Florida
Co-authored papers 2
Universidade Federal do Rio Grande do Norte
Co-authored papers 2
The Hospital for Sick Children
Co-authored papers 2
Center for Pharmacogenomics and Precision Medicine, University of Florida
Co-authored papers 2
Japanese Foundation for Cancer Research
Co-authored papers 2
Vanderbilt University Medical Center
Co-authored papers 1
H. Lee Moffitt Cancer Center & Research Institute
Co-authored papers 1
Co-authored papers 1
The Hastings Center
Co-authored papers 1
Center for Precision Medicine and Functional Genomics, Utah Tech University
Co-authored papers 1
Vanderbilt University
Co-authored papers 1
Co-authored papers 1
University of Toronto
Co-authored papers 1